ArticleOncotarget2017

Tumor-infiltrating lymphocytes predict prognosis of breast cancer patients treated with anti-Her-2 therapy.

Tan-Huan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.